Market Place
Sourcing Support
Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109
17 Oct 2022 //
PRESS RELEASE
Apnimed to Participate in the Annual Needham Biotech Company Virtual 1x1 Forum
12 Oct 2022 //
BUSINESSWIRE
New Data Show Meaningful Improvements for AD504 in Obstructive Sleep Apnea
02 Jun 2022 //
BUSINESSWIRE
OWP Pharma Announces IND Authorization for the 1st-Ever Oral Liquid Formulation
17 Nov 2021 //
GLOBENEWSWIRE
Apnimed sees positives in new sleep apnea drug data
14 Oct 2021 //
FIERCEBIOTECH
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid
22 Apr 2021 //
GLOBENEWSWIRE
Dr. Reddys Labs Generic Atomoxetine Hydrochloride Receives Approval In US
27 Feb 2018 //
FDA
Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents
17 Aug 2017 //
STAT
Stampeding generics expected to trample Lilly`s now-off-patent med Strattera
01 Jun 2017 //
FIERCE PHARMA
FDA approves first generic Strattera for the treatment of ADHD
30 May 2017 //
PR NEWSWIRE
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Eli Lilly targets sales force for job cuts in wake of Alzheimer`s failure
07 Dec 2016 //
FIERCE PHARMA
Shire launches long-acting ADHD drug Intuniv in UK
09 Mar 2016 //
PM LIVE
Lilly falls short of analyst forecasts with 2016 guidance on the `weaker end`
05 Jan 2016 //
FIERCE PHARMA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Health Canada issues “stronger, clearer” warnings about suicide risks linked to ADHD drugs
03 Apr 2015 //
THE STAR
ADHD Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks
01 Apr 2015 //
HEALTHY CANADIANS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.